I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 13 studies | 30% ± 11% | |
| astrocyte | 8 studies | 29% ± 12% | |
| natural killer cell | 6 studies | 20% ± 3% | |
| CD16-positive, CD56-dim natural killer cell, human | 6 studies | 18% ± 4% | |
| epithelial cell | 6 studies | 27% ± 5% | |
| plasmacytoid dendritic cell | 6 studies | 18% ± 2% | |
| endothelial cell of lymphatic vessel | 5 studies | 26% ± 7% | |
| ciliated cell | 4 studies | 20% ± 7% | |
| smooth muscle cell | 4 studies | 21% ± 4% | |
| macrophage | 4 studies | 23% ± 4% | |
| conventional dendritic cell | 3 studies | 31% ± 5% | |
| non-classical monocyte | 3 studies | 22% ± 7% | |
| retinal cone cell | 3 studies | 20% ± 4% | |
| retinal rod cell | 3 studies | 20% ± 3% | |
| hepatocyte | 3 studies | 47% ± 10% | |
| dendritic cell | 3 studies | 27% ± 9% | |
| hematopoietic stem cell | 3 studies | 29% ± 15% | |
| mast cell | 3 studies | 17% ± 0% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 45% ± 19% |
